【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, September 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, September 2013 14
2.2.1 Tenet Healthcare Prices Private Placement of Notes for US$4.6 Billion 14
2.2.2 Fresenius to Acquire 43 Hospitals from Rhon-Klinikum for US$4.1 Billion 14
2.2.3 Suntory Beverage to Acquire Lucozade and Ribena Brands from GlaxoSmithKline for US$2.1 Billion 15
2.2.4 Aspen Pharmacare to Acquire Thrombosis Brands and Manufacturing Facility from GlaxoSmithKline for US$1.13 Billion 16
2.2.5 AbbVie Enters Into Licensing Agreement with Ablynx for ALX-0061 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, September 2013 18
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, September 2013 19
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20
3.1 Pharmaceuticals & Healthcare, Global, M&A, September 2013 20
3.1.1 Top M&A Deals in September 2013 21
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, April 2013 – September 2013 22
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, September 2013 24
3.2.1 Top Equity Offering Deals in September 2013 26
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, April 2013 – September 2013 27
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, September 2013 29
3.3.1 Top PE/VC Deals in September 2013 31
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, September 2013 32
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, September 2013 34
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, April 2013-September 2013 36
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, April 2013-September 2013 38
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, September 2013 39
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, September 2013 39
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, April 2013 – September 2013 41
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), September 2013 43
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, September 2013 44
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), April 2013 – September 2013 45
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, April 2013 – September 2013 47
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), April 2013 – September 2013 48
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), April 2013 – September 2013 50
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, September 2013 52
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, September 2013 52
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), September 2013 54
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, September 2013 56
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, September 2013 56
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, September 2013 57
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), April 2013 – September 2013 58
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), April 2013 – September 2013 60
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), April 2013 – September 2013 62
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), April 2013 – September 2013 64
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 66
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, September 2013 66
6.1.1 Oncology – Deals of the Month 68
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, September 2013 70
6.2.1 Central Nervous System – Deals of the Month 71
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, September 2013 72
6.3.1 Infectious Diseases – Deals of the Month 74
6.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, September 2013 75
6.4.1 Immunology – Dealsof the Month 77
6.5 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, September 2013 78
6.5.1 Respiratory – Deal of the Month 80
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, September 2013 81
6.6.1 Cardiovascular – Deal of the Month 83
6.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, September 2013 84
6.7.1 Metabolic Disorders – Deal of the Month 86
7 Deal Summary by Geography 87
7.1 Pharmaceuticals & Healthcare, North America Deals, September 2013 87
7.1.1 North America – Deals of the Month 89
7.2 Pharmaceuticals & Healthcare, Europe, Deals, September 2013 92
7.2.1 Europe – Deals of the Month 94
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, September 2013 96
7.3.1 Asia-Pacific – Deals of the Month 98
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, September 2013 99
7.4.1 Rest of the World – Deals of the Month 100
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 101
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, April 2013 – September 2013 101
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, April 2013 – September 2013 103
9 Further Information 105
9.1 Methodology 105
9.2 About GlobalData 106
9.3 Disclosure information 107
9.4 Disclaimer 107
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：September 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for September 2013 in Pharmaceuticals
■ 発行日：2013年10月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403162558
■ 調査対象地域：グローバル
- 世界のタバコ産業分析：Analyzing the Global Tobacco IndustryThere is no denying the fact that in spite of a global economic downturn, lawsuits, health problems, and rising prices of cigarettes, the global tobacco industry has continued to generate strong growth as well as profits. Many legal problems continue to plague the global tobacco industry as governments around the world continue to put in place strict regulations to curb the use of tobacco. The hea …
- 炭素繊維プリプレグの世界市場The global carbon fiber prepreg market was valued at $2,633.0 million in 2014 and is estimated to reach $4,640.2 million by 2019, at a CAGR of 11.9% during the period under consideration. In this report, the global carbon fiber prepreg market has been broadly classified on the basis of application and geography. The application segment is divided into aerospace & defense, wind, sporting goods, and …
- 洗濯物乾燥キャビネットの世界市場2018-2022About Laundry Drying Cabinets Cabinets used to dry wet and washed clothes, and previously-worn (unwashed) clothes are called laundry drying cabinets. They are operated by the vented drying and heat pump drying technology. Few of the cabinets also have steaming features. Technavio’s analysts forecast the global laundry drying cabinets market to grow at a CAGR of 5.52% during the period 2018-2022. C …
- 小腸結腸炎(Enterocolitis)：世界の治験レビュー（2015年上半期版）Enterocolitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Enterocolitis Global Clinical Trials Review, H1, 2015" provides data on the Enterocolitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Enterocolitis. It includes an overview of the trial numbers and their recruitment status as per the …
- 世界のプロバイオティックス市場This report analyses the Probiotic market by geography, applications, products, and ingredients in the probiotics market. In terms of geography, the report is segmented into Asia-Pacific, Europe, North America, and Rest of the World. The probiotic product segment included in this report is based on popular variants, i.e. functional food & beverages, dietary supplements, specialty nutrients, and an …
- Anal Cancer：グローバル臨床試験レビューH2, 2013Anal Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Anal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Anal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of …
- 飼料用酵母の世界市場予測（～2022年）The feed yeast market is projected to grow at a CAGR of 8.21% during the forecast period, to reach a projected value of USD 602.8 Million by 2022. The demand for feed yeast is largely dependent on the increase in demand for livestock produce such as meat & meat products and dairy products. The rise in awareness about the health benefits of yeast such as enhanced gut flora, improved immune system, …
- 世界の防音材市場2015The Global Acoustic Insulation material Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Acoustic Insulation material industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Acoustic Insulation material market analysis is provided for the international m …
- Strike Energy Limited：石油・ガスの開発・生産動向及びコスト分析– 2012Strike Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Strike Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 殺線虫剤の世界市場：燻蒸剤、有機燐剤、カルバマート、バイオ殺線虫剤About Nematicides Nematicides are a class of pesticides that inhibit or kill plant-parasitic nematodes. Rise in global demand for food has increased the pressure on famers to enhance their crop yield. Hence, farmers are increasingly adopting nematicides to prevent loss of crops from parasitic attacks. The commonly used nematicides include fumigants, organophosphates, carbamates, bio-nematicides, a …
- 自動車用パッシブキーレスエントリー（PKE）システムの世界市場About the Automotive Passive Keyless Entry Systems Market PKE systems are the most advanced keyless entry system currently available. These systems operate with two integrated circuits that act as radio transmitters — one is placed in the key fob and the other inside the vehicle. Both these transmitters have to communicate with each other to lock/unlock vehicle doors and to activate the ignition s …
- 代替･補完医療の世界市場分析：療法別（植物学、鍼灸、精神、身体、およびヨガ、磁気療法）、分配方法別、セグメント予測 -2013-2025The complementary & alternative medicine market is expected to generate a revenue of USD 196.87 billion by 2025, according to a new report by Grand View Research, Inc. Factors such as the increase in adoption of alternative medicine by people combined with the government initiatives of a number of key countries to enhance reach is expected to help in expansion revenue generation avenues. Complemen …
- プラスチック用添加剤の世界市場：可塑剤、安定剤、難燃剤、耐衝撃性改良剤Additives are added in plastics to improve its impact strength, chemical and heat resistance, clarity, weather resistance and color preservation properties. Plastic additives are used to add volume in order to control costs, modify the physical or chemical properties of the polymer, or reinforcing the polymer’s mechanical properties to make it stronger and better for end-use applications. Plastics …
- ココナッツミルクの世界市場2016-2020About Coconut MilkCoconut milk is a sweet, milky white liquid obtained from the grated meat of mature coconut. The rich taste and color of coconut milk can be attributed to the high oil and sugar contents in it. It is one of the main ingredients of Southeast Asian cuisine and is used for making curries, deserts, and sweets. Coconut milk is consumed as a drink and is also used as a cooking ingredie …
- 3Dプリンティングの世界市場：プリンター、材料、材料の形状、プロセス、技術、ソフトウェア、サービス、用途、産業、地域別分析The global 3D printing market is expected to grow from USD 4.98 Billion in 2015 to USD 30.19 Billion by 2022, at a CAGR of 28.5% between 2016 and 2022. The market is expected to be driven by factors such as ease of developing customized products, benefits of 3D printing, and government investments in 3D printing projects. The market for desktop 3D printers is expected to grow at a high rate during …
